Impact of initial Norwood shunt type on young hypoplastic left heart syndrome patients listed for heart transplant: A multi-institutional study  Waldemar.

Slides:



Advertisements
Similar presentations
ABO-incompatible heart transplantation in early childhood: An international multicenter study of clinical experiences and limits Simon Urschel, MD, Ingrid.
Advertisements

Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service.
Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke Michael E. Nassif, MD, Anjan Tibrewala,
Sixth INTERMACS annual report: A 10,000-patient database James K. Kirklin, MD, David C. Naftel, PhD, Francis D. Pagani, MD, PhD, Robert L. Kormos, MD,
Janet T. Lee, MD, Rosemary F. Kelly, MD, Marshall I
Predictors of survival in restrictive chronic lung allograft dysfunction after lung transplantation  Stijn E. Verleden, PhD, David Ruttens, MD, Elly Vandermeulen,
Evan P. Kransdorf, MD, PhD, Michelle M. Kittleson, MD, PhD, Jignesh K
Patterns and Predictors of Physical Functional Disability at 5 to 10 Years After Heart Transplantation  Kathleen L. Grady, PhD, RN, David C. Naftel, PhD,
De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation 
Orlando Petrucci, MD, PhD, Philip R. Khoury, MS, Peter B
Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device  David Dobarro, MD, Marian Urban, MD, Karen.
James K. Kirklin, MD, Francis D. Pagani, MD, PhD, Robert L
Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with.
Can the Seattle Heart Failure Model Be Used to Risk-stratify Heart Failure Patients for Potential Left Ventricular Assist Device Therapy?  Wayne C. Levy,
Marcello Gomide, MD, Barbara Furci, MD, Branko Mimic, MD, Kate L
Low vitamin D levels are associated with increased rejection and infections after lung transplantation  Erin M. Lowery, MD, Bradford Bemiss, MD, Thomas.
The Journal of Heart and Lung Transplantation
Limitations of right heart catheterization in the diagnosis and risk stratification of patients with pulmonary hypertension related to left heart disease:
Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: Application of the HeartMate II risk score 
Adverse Events in Children Implanted With Ventricular Assist Devices in the US: Data From the Pediatric Interagency Registry for Mechanical Circulatory.
Outcomes in highly sensitized pediatric heart transplant patients using current management strategies  Alfred Asante-Korang, MD, Ernest K. Amankwah, PhD,
Two decades of pediatric lung transplant in the United States: Have we improved?  Farhan Zafar, MD, Jeffrey S. Heinle, MD, Marc G. Schecter, MD, Joseph.
Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients  James K. Kirklin, MD, David C. Naftel,
Impact of Race on Outcomes of Patients with Non-small Cell Lung Cancer
Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L
The impact of a dedicated single-ventricle home-monitoring program on interstage somatic growth, interstage attrition, and 1-year survival  Christopher.
Hybrid Procedure for Neonates With Hypoplastic Left Heart Syndrome at High-Risk for Norwood: Midterm Outcomes  Michael O. Murphy, MD, MRCP, Hannah Bellsham-Revell,
Orlando Petrucci, MD, PhD, Philip R. Khoury, MS, Peter B
Volume 146, Issue 5, Pages e1 (May 2014)
Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures  J. Saravana Ganesh, FRCS, Chris.
Outcome of 200 patients after an extracardiac Fontan procedure
Pirooz Eghtesady, MD, PhD, Anoop Brar, PhD, Matthew Hall, PhD 
Marcello Gomide, MD, Barbara Furci, MD, Branko Mimic, MD, Kate L
Interstage attrition between bidirectional Glenn and Fontan palliation in children with hypoplastic left heart syndrome  Waldemar F. Carlo, MD, Kathleen.
Exposure to Nitrofurantoin During Early Pregnancy and Congenital Malformations: A Systematic Review and Meta-Analysis  Ori Goldberg, MD, MPH, Myla Moretti,
Prospective follow-up study of children with univentricular heart: Neurodevelopmental outcome at age 12 months  Anne Sarajuuri, MD, Tuula Lönnqvist, MD,
Impact of Blalock-Taussig Shunt Size on Tricuspid Regurgitation in Hypoplastic Left Heart Syndrome  Hiroko Asakai, MD, John C. Galati, BSc, PhD, Sofia.
A Phase II Trial of Carboplatin and Weekly Topotecan in the First-Line Treatment of Patients with Extensive Stage Small Cell Lung Cancer  David R. Spigel,
The Optimal Timing of Stage-2-Palliation After the Norwood Operation
Samuel J. Wang, MD, PhD, C David Fuller, MD, Charles R. Thomas, MD 
Gilbert H. L. Tang, MD, MSc, Ramin Malekan, MD, Cindy J
Long-term mechanical circulatory support (destination therapy): On track to compete with heart transplantation?  James K. Kirklin, MD, David C. Naftel,
Outcomes in lung transplantation after previous lung volume reduction surgery in a contemporary cohort  Leah Backhus, MD, Jonathon Sargent, BS, Aaron.
David L. S. Morales, MD, William J. Dreyer, MD, Susan W
Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database  Laura C. Caprario, MD, MS,
Intermediate outcomes after the Fontan procedure in the current era
Atrioventricular valve repair in patients with functional single-ventricle physiology: Impact of ventricular and valve function and morphology on survival.
Elizabeth A. David, MD, MAS, Stina W. Andersen, PhD, Laurel A
Intermediate-term mortality and cardiac transplantation in infants with single-ventricle lesions: Risk factors and their interaction with shunt type 
Volume 77, Issue 2, Pages (January 2010)
Aditya K. Kaza, MD  The Journal of Thoracic and Cardiovascular Surgery 
Volume 133, Issue 2, Pages (August 2007)
A contemporary comparison of the effect of shunt type in hypoplastic left heart syndrome on the hemodynamics and outcome at Fontan completion  Jean A.
Psoriasis May Not be an Independent Risk Factor for Acute Ischemic Heart Disease Hospitalizations: Results of a Large Population-Based Dutch Cohort  Marlies.
Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011  William L.
Raheel Rizwan, MD, Farhan Zafar, MD, Roosevelt Bryant, MD, James S
William L. Holman, MD, James K. Kirklin, MD, David C
André Rüffer, MD, Florian Arndt, MD, Sergej Potapov, MS, Thomas S
Volume 135, Issue 4, Pages (October 2008)
The use of mechanical circulatory support as a bridge to transplantation in pediatric patients: An analysis of the United Network for Organ Sharing database 
Brian M. Cardis, MD, Derek A. Fyfe, MD, PhD, William T. Mahle, MD 
Impact of antibodies against human leukocyte antigens on long-term outcome in pediatric heart transplant patients: An analysis of the United Network for.
Racial differences in survival of patients on dialysis
Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD 
Wedge Resection for Non-small Cell Lung Cancer in Patients with Pulmonary Insufficiency: Prospective Ten-Year Survival  John P. Griffin, MD, Charles E.
Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement  Todd M. Dewey,
Long-term results of heart transplantation in patients older than 60 years  Philippe Demers, MD, MSc, FRCSC, Susan Moffatt, MD, PhD, FRCSC, Philip E Oyer,
Perioperative monitoring in high-risk infants after stage 1 palliation of univentricular congenital heart disease  Nancy S. Ghanayem, MD, George M. Hoffman,
How do we follow up our patients
Kathleen E. Simpson, MD, Elizabeth Pruitt, MSPH, James K
Presentation transcript:

Impact of initial Norwood shunt type on young hypoplastic left heart syndrome patients listed for heart transplant: A multi-institutional study  Waldemar F. Carlo, MD, Shawn C. West, MD, MSc, Michael McCulloch, MD, David C. Naftel, PhD, Elizabeth Pruitt, MSPH, James K. Kirklin, MD, Meloneysa Hubbard, MSN, Kimberly M. Molina, MD, Robert Gajarski, MD, MHSA  The Journal of Heart and Lung Transplantation  Volume 35, Issue 3, Pages 301-305 (March 2016) DOI: 10.1016/j.healun.2015.10.032 Copyright © 2016 International Society for Heart and Lung Transplantation Terms and Conditions

Figure 1 Competing outcomes after listing for HLHS patients <6 years old who were listed for transplantation in the MBT (A) and RVPA (B) cohorts between 2010 and 2013. The Journal of Heart and Lung Transplantation 2016 35, 301-305DOI: (10.1016/j.healun.2015.10.032) Copyright © 2016 International Society for Heart and Lung Transplantation Terms and Conditions

Figure 2 Kaplan–Meier analysis of survival after listing for HLHS patients in the MBT and RVPA cohorts. Survival curves were constructed with censoring at the time of transplant. The Journal of Heart and Lung Transplantation 2016 35, 301-305DOI: (10.1016/j.healun.2015.10.032) Copyright © 2016 International Society for Heart and Lung Transplantation Terms and Conditions

Figure 3 Kaplan–Meier analysis of survival after listing for HLHS infants <1 year of age in the MBT and RVPA cohorts based on the presence of Glenn physiology. Survival curves were constructed with censoring at the time of transplant. The Journal of Heart and Lung Transplantation 2016 35, 301-305DOI: (10.1016/j.healun.2015.10.032) Copyright © 2016 International Society for Heart and Lung Transplantation Terms and Conditions

Figure 4 Kaplan–Meier analysis of survival after transplant for HLHS patients in the MBT and RVPA cohorts. The Journal of Heart and Lung Transplantation 2016 35, 301-305DOI: (10.1016/j.healun.2015.10.032) Copyright © 2016 International Society for Heart and Lung Transplantation Terms and Conditions